202 related articles for article (PubMed ID: 10509166)
1. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
[No Abstract] [Full Text] [Related]
2. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
[TBL] [Abstract][Full Text] [Related]
3. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
Dahan L; Ressiot E; Cournede A; Ries P; Duluc M; Laquiere A; Laugier R; Braguer D; Seitz JF
Gastroenterol Clin Biol; 2007 Dec; 31(12):1143-5. PubMed ID: 18176375
[TBL] [Abstract][Full Text] [Related]
4. Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.
Sawai H; Okada Y; Tanaka M; Funahashi H; Yamamoto M; Takeyama H; Manabe T
Dig Dis Sci; 2006 Jul; 51(7):1285-9. PubMed ID: 16944027
[No Abstract] [Full Text] [Related]
5. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
[TBL] [Abstract][Full Text] [Related]
6. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
[TBL] [Abstract][Full Text] [Related]
7. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
8. Cutaneous metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case treated with gemcitabine.
Takemura N; Fujii N; Tanaka T
J Dermatol; 2007 Sep; 34(9):662-4. PubMed ID: 17727372
[No Abstract] [Full Text] [Related]
9. Severe acute lung injury induced by gemcitabine.
Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
11. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
Saadati H; Saif MW
JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
[No Abstract] [Full Text] [Related]
12. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
13. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
Shaib W; Lansigan F; Cornfeld D; Syrigos K; Saif MW
JOP; 2008 Nov; 9(6):708-14. PubMed ID: 18981552
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
El-Rayes BF; Zalupski MM; Shields AF; Ferris AM; Vaishampayan U; Heilbrun LK; Venkatramanamoorthy R; Adsay V; Philip PA
Invest New Drugs; 2005 Dec; 23(6):583-90. PubMed ID: 16034525
[TBL] [Abstract][Full Text] [Related]
15. Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
Assi C; Lepage C; Jouve JL; Sgro C; Bedenne L
Gastroenterol Clin Biol; 2010 Nov; 34(11):640-2. PubMed ID: 21051168
[No Abstract] [Full Text] [Related]
16. Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Alberts SR; Schroeder M; Erlichman C; Steen PD; Foster NR; Moore DF; Rowland KM; Nair S; Tschetter LK; Fitch TR
J Clin Oncol; 2004 Dec; 22(24):4944-50. PubMed ID: 15611509
[TBL] [Abstract][Full Text] [Related]
17. Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
Vansteenkiste JF; Bomans P; Verbeken EK; Nackaerts KL; Demedts MG
Lung Cancer; 2001 Jan; 31(1):83-5. PubMed ID: 11162870
[No Abstract] [Full Text] [Related]
18. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Pavlakis N; Bell DR; Millward MJ; Levi JA
Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
[TBL] [Abstract][Full Text] [Related]
19. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
Biswas S; Nik S; Corrie PG
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
[TBL] [Abstract][Full Text] [Related]
20. Safety of capecitabine use in patients with liver dysfunction.
Saif MW; Tejani MA
Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
